Kyle Mikson
Stock Analyst at Canaccord Genuity
(n/a)
# 4,303
Out of 4,667 analysts
65
Total ratings
n/a
Success rate
-45.97%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AKYA Akoya Biosciences | Maintains: Buy | $6 → $3.5 | $2.24 | +56.25% | 3 | Nov 15, 2024 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $3 | $0.99 | +203.00% | 4 | Nov 14, 2024 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1.5 → $1 | $1.29 | -22.49% | 3 | Nov 13, 2024 | |
| NTRA Natera | Maintains: Buy | $150 → $165 | $169.10 | -2.42% | 5 | Nov 13, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $95 → $75 | $53.48 | +40.23% | 9 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Hold | $130 → $145 | $133.62 | +8.52% | 6 | Nov 5, 2024 | |
| CSTL Castle Biosciences | Maintains: Buy | $35 → $42 | $28.91 | +45.28% | 3 | Oct 29, 2024 | |
| TXG 10x Genomics | Maintains: Buy | $32 → $20 | $13.33 | +50.04% | 6 | Oct 10, 2024 | |
| PACB Pacific Biosciences of California | Maintains: Buy | $3.5 → $3 | $1.78 | +69.01% | 7 | Aug 8, 2024 | |
| TTOO T2 Biosystems | Maintains: Hold | $3 → $5 | $0.45 | +1,011.11% | 3 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $38 | $30.51 | +24.55% | 4 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $25 | $10.99 | +127.48% | 4 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.21 | +190.46% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.84 | +138.10% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $4.38 | +59.93% | 1 | Nov 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $1.07 | +4,517.55% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $1.51 | +1,160.03% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $0.73 | +20,566.85% | 1 | Jan 29, 2021 |
Akoya Biosciences
Nov 15, 2024
Maintains: Buy
Price Target: $6 → $3.5
Current: $2.24
Upside: +56.25%
Lucid Diagnostics
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $0.99
Upside: +203.00%
Quantum-Si incorporated
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.29
Upside: -22.49%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $150 → $165
Current: $169.10
Upside: -2.42%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $53.48
Upside: +40.23%
Illumina
Nov 5, 2024
Maintains: Hold
Price Target: $130 → $145
Current: $133.62
Upside: +8.52%
Castle Biosciences
Oct 29, 2024
Maintains: Buy
Price Target: $35 → $42
Current: $28.91
Upside: +45.28%
10x Genomics
Oct 10, 2024
Maintains: Buy
Price Target: $32 → $20
Current: $13.33
Upside: +50.04%
Pacific Biosciences of California
Aug 8, 2024
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.78
Upside: +69.01%
T2 Biosystems
Jul 30, 2024
Maintains: Hold
Price Target: $3 → $5
Current: $0.45
Upside: +1,011.11%
Jun 4, 2024
Maintains: Buy
Price Target: $30 → $38
Current: $30.51
Upside: +24.55%
Apr 29, 2024
Maintains: Buy
Price Target: $32 → $25
Current: $10.99
Upside: +127.48%
Mar 4, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.21
Upside: +190.46%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.84
Upside: +138.10%
Nov 15, 2022
Maintains: Buy
Price Target: $8 → $7
Current: $4.38
Upside: +59.93%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $1.07
Upside: +4,517.55%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $1.51
Upside: +1,160.03%
Jan 29, 2021
Initiates: Overweight
Price Target: $150
Current: $0.73
Upside: +20,566.85%